Skip to main content

Table 1 The characteristics of eight CRC patients in our study

From: Multi-omics analyses of human colorectal cancer revealed three mitochondrial genes potentially associated with poor outcomes of patients

 

I–II

III–IV

Age

 ≤ 65

0 (0.0%)

1 (12.5%)

 > 65

4 (50.0%)

3 (37.5%)

Type

 Adenocarcinoma

4 (50.0%)

4 (50.0%)

Sex

 Male

1 (12.5%)

3 (37.5%)

 Female

3 (37.5%)

1 (12.5%)

T-stage

 T1

1 (12.5%)

0 (0.0%)

 T2

0 (0.0%)

0 (0.0%)

 T3

2 (25.0%)

1 (12.5%)

 T4

1 (12.5%)

3 (37.5%)

N-stage

 N0

4 (50.0%)

0 (0.0%)

 N1

0 (0.0%)

4 (50.0%)

 N2

0 (0.0%)

0 (0.0%)

M-stage

 M0

4 (50.0%)

1 (12.5%)

 M1

0 (0.0%)

3 (37.5%)

Location

 Ascending colon

2 (25.0%)

1 (12.5%)

 Sigmoid colon

1 (12.5%)

3 (37.5%)

 Appendix colon

1 (12.5%)

0 (0.0%)

Chemotherapy

 Yes

0 (0.0%)

0 (0.0%)

 No

4 (50.0%)

4 (50.0%)